Le Lézard
Classified in: Health
Subject: SVY

US Outpatient Surgical Procedures Market to Reach 144 Million Procedures by 2023 - Exclusive Report by MarketsandMarketstm


CHICAGO, January 21, 2019 /PRNewswire/ --

According to the new market research report  "US Outpatient Surgical Procedures Market by Surgical Procedure Type (Gastrointestinal, Cardiovascular, Neurological, Orthopedic, Gynecologic, Integumentary, Ophthalmic), Patient Care Setting (Physician's Office, Hospital OPDs, ASCs) - US Forecast to 2023", published by MarketsandMarketstm, The number of outpatient surgical procedures in the US is expected to grow from ~129 million procedures in 2018 to ~144 million procedures by 2023, at a CAGR of 2.1% during the forecast period.

     (Logo: https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg )

Don't miss out on business opportunities in US Outpatient Surgical Procedures Market

The growing number of outpatient surgeries is expected to increase the adoption of capnography monitoring devices in outpatient surgical departments in the US.

Inquiry Before Buying:  

https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=94756744

The dental surgeries segment is expected to command the largest share of the overall outpatient surgical procedures market in the US during the forecast period. 

By type, the dental surgeries segment accounted for the largest share of the US Outpatient Surgical Procedures Market in 2018. The large share of this market segment can be attributed to the large number of dental surgeries performed in physicians' offices in the US, which require minimal sedation.

Browse and in-depth TOC on "US Outpatient Surgical Procedures Market"  

14 - Tables 

32 - Figures  

59 - Pages  

Get Free 10% customization:  

https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=94756744

The other surgeries segment is expected to grow at the highest CAGR during the forecast period. 

Other surgeries performed in outpatient departments include surgeries of the nervous system (laminectomy and excision of the intervertebral disc and decompression of the peripheral nerve), endocrine system (partial or complete thyroidectomy), and integumentary system (mastectomy and lumpectomy). Growth in this market segment can largely be attributed to the increasing prevalence of disorders of the intervertebral disc, peripheral nerves, and glands as well as growth in the burden of breast cancer.

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarketstm: 

MarketsandMarketstm provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarketstm for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarketstm are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarketstm now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarketstm is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarketstm INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : +1-888-600-6441
Email: [email protected]

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/us-outpatient-surgical-procedures-market.asp

Visit Our Website: https://www.marketsandmarkets.com

SOURCE MarketsandMarkets


These press releases may also interest you

18 avr 2024
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

18 avr 2024
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

18 avr 2024
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

18 avr 2024
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

18 avr 2024
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

18 avr 2024
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: